Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorNew York Medical College
About this trial
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are:
* To determine the extent to which this combined treatment can improve language. * To determine the extent to which the combined treatment can improve arm movements.
Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Eligibility criteria
Qualifiers
Male or female patients between 18-90 years of age.
Right-handed prior to stroke
English-speaking (monolingual)
History of single left-hemisphere stroke at least 6 months prior to enrollment
Disqualifiers
Diagnosis or history of speech impairment prior to stroke
Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R)
Inability to perform screening tasks due to severe language and/or cognitive impairment
Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture)
Trial design
Treatments tested in this trial
- CARAT: combined aphasia and robot-assisted arm therapy
- Robot-assisted arm therapy
Treatment groups
28 Participants
are divided into 2 treatment groupsSponsors and collaborators
New York Medical College
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
New York University
Collaborator
Source ClinicalTrials.gov